Back to results
US 2002/0006408 A1Published application
Vaccines against eimeria mediated disorder
OwnerArno N Vermeulen, Dominique G J Clercx-Breedinventors
Life of this patent
Estimating the term…
Abstract
Compositions comprising Eimeria proteins or variants/fragments of such proteins can be used to produce a coccidiosis vaccine. The proteins are present in the hydrophilic phase of a Triton X-114 extract of Eimeria sporozoites and have molecular masses of 26-30 kDa±5 kDA when determined by SDS PAGE under reducing conditions.
Claims21
A composition free of whole Eimeria parasites, which comprises one or more proteins, or fragments or variants thereof;
- wherein said proteins:
- (a) are present in the hydrophilic phase of a Triton X-114 extract of Eimeria sporozoites
- (b) have molecular masses of 26-30 kDa±5 kDa (i.e. 21-35 kDa) when determined by SDS-PAGE under reducing conditions.
A composition according to any preceding claim wherein a plurality (e.g. two or three of said proteins, fragments or variants thereof are present).
Dependencies are inferred from the claim text.